藏药镰形棘豆黄酮泡腾片制剂工艺及抗氧化活性研究
赵文瑄, 张瑞, 黄世玲, 林鹏程, 何彦峰
西南民族大学学报(自然科学版) ›› 2026, Vol. 52 ›› Issue (4) : 410 -418.
藏药镰形棘豆黄酮泡腾片制剂工艺及抗氧化活性研究
Pharmaceutical technology and antioxidant activity of Tibetan medicine Oxytropis falcata Bunge flavonoid effervescent tablets
为提高镰形棘豆药用植物资源在医药领域的开发与应用,利用干法制粒压片法将在一定条件下提取的镰形棘豆总黄酮制备为镰形棘豆黄酮泡腾片,通过Design-Expert 13软件进行实验设计,优化镰形棘豆泡腾片配方;通过测定镰形棘豆黄酮泡腾片理化指标以及对自由基的清除能力,评价其质量与体外的抗氧化能力.结果表明:当镰形棘豆总黄酮提取物添加量为6.0%(m/m,下同)、崩解剂50.0% (柠檬酸—碳酸氢钠配比为1.0∶0.7)、麦芽糊精30%、可溶性淀粉9.0%、聚乙烯吡咯烷酮1.5%、硬脂酸镁1.5%、微晶纤维素1.5%时,泡腾片的配方最佳.最佳配方下的镰形棘豆黄酮泡腾片平均片重为(406.0±0.7)mg;脆碎度为0.74%;发泡量为(6.6±0.3)mL;崩解时间为(197.00±3.05)s; pH值为5.1±0.1;黄酮含量为(33.40±0.03)mg/g.镰形棘豆黄酮泡腾片对DPPH(1,1-二苯基-2-三硝基苯肼)、ABTS(2,2′-联氮双(3-乙基苯并噻唑啉-6-磺酸)二铵盐)、·OH的半抑制浓度(IC50)别分为0.64、0.52、1.06 mg/mL.镰形棘豆黄酮泡腾片工艺稳定可行,具有较好的抗氧化活性.研究结果为藏药镰形棘豆在医药领域的开发与利用提供理论依据和实践基础.
To promote the development and application of medicinal plant Oxytropis falcata Bunge in the field of medicine, this study employed dry granulation and tableting methods to prepare O. falcata flavonoid effervescent tablets by utilizing total flavonoids extracted in certain conditions. Design-Expert 13 software was adopted for experimental design to optimize the formulation of the effervescent tablets. The quality and in vitro antioxidant activity were evaluated by measuring the physicochemical indexes and free radical scavenging capacity of the tablets. The results showed that the formulation of O. falcata flavonoid effervescent tablets was the best when the content of total flavonoid extract of O. falcata was 6.0% (m/m, the same below), disintegrating agent content was 50.0% (1.0:0.7 for the ratio of citric acid to sodium bicarbonate), maltodextrin content was 30.0%, soluble starch content was 9.0%, polyvinylpyrrolidone content was 1.5%, magnesium stearate content was 1.5%, and microcrystalline cellulose was 1.5%. Under the best formulation, the average weight of O. falcata flavonoid effervescent tablets was (406.0±0.7) mg, friability was 0.74%, foaming volume was (6.6±0.3) mL, and disintegration time was (197.00±3.05) s, with the pH value of 5.1±0.1 and flavonoid content of (33.40±0.03) mg/g. The half maximal inhibitory concentration (IC50) values of flavonoid effervescent tablets for 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)diammonium salt (ABTS), and ·OH were 0.64, 0.52, and 1.06 mg/mL, respectively. The pharmaceutical technology of O. falcata flavonoid effervescent tablets demonstrated stability, feasibility, and excellent antioxidant activity. This study provided a theoretical and practical basis for the development and utilization of Tibetan medicine O. falcata in the field of medicine.
| [1] |
|
| [2] |
中华人民共和国卫生部. 中华人民共和国卫生部药品标准:藏药(第一册) [S].北京:中华人民共和国卫生部,1995:340. |
| [3] |
李玉林,廖志新,杜玉枝.棘豆属植物化学成分研究概况[J].天然产物研究与开发,2002,14(5):75. |
| [4] |
才让草,李魁,杨红岩, |
| [5] |
刘斌.中国棘豆属药用植物及其现代研究[J].中国野生植物资源,1997,(02):17-20+39. |
| [6] |
青海省生物研究所,同仁县隆务诊疗所, |
| [7] |
|
| [8] |
李茂星,尉丽力,邱建国, |
| [9] |
姜华,胡君茹,程晓华, |
| [10] |
杨光明,张芳芳,王栋, |
| [11] |
杨钦磊,韩秋惠.藏药镰形棘豆的有效成分及临床应用的研究[J].海峡药学,2019,31(12):46-49. |
| [12] |
陈冰瑶.蓝靛果全果冻干粉泡腾片的研制[D].太原:沈阳农业大学,2020. |
| [13] |
殷晓娇.东北黑蜂蜂王浆真空冷冻干燥关键技术及蜂王浆泡腾片的制备[D].长春:吉林农业大学,2021. |
| [14] |
赵祎.啤酒泡腾片的生产加工工艺[J].吉林农业,2018(15):57-58. |
| [15] |
|
| [16] |
刘素连,张锐锐,许有瑞.罗汉果复合饮料泡腾片的研制[J].食品科技,2020,45(01):154-160. |
| [17] |
何彦峰,杨仁明,胡娜, |
| [18] |
胡娜,杨仁明,何彦峰, |
| [19] |
谢奥,赵文瑄,张瑞, |
| [20] |
查晓彤,裴宇芳,马瑞雪, |
| [21] |
徐树来,李珂,刘程程, |
| [22] |
陈俊,唐其蔚,胡秀虹, |
| [23] |
崔冬安,陈浩,周海园, |
| [24] |
李园园,杨文超,叶丹榕, |
| [25] |
郑彩美,王育婷,黄华花, |
| [26] |
陈静,鲁思祺,赵永恒, |
| [27] |
郭新颖,李晨阳,王梦晗, |
| [28] |
李珊,刘哲,赵永珍, |
| [29] |
宋晓凡,李岩,张一茹, |
| [30] |
余芳.药食同源复合泡腾片研究进展[J].江苏调味副食品,2024,(03):1-5. |
| [31] |
李晓,孔欣欣,王成, |
| [32] |
王菲,沈卉芳,王瑶, |
| [33] |
代甜甜,张晓春,吴娜怡郁, |
| [34] |
陶悦,王孜硕,张坤, |
/
| 〈 |
|
〉 |